Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients

Journal of Periodontology

Volumn 75, Issue 1, 2004, Pages 91-97

  Güneri, Pelin ^a   Ünlü, Füsun ^a   Yeşilbek, Banu ^a   Bayraktar, Firat ^b   Kokuludaǧ, Ali ^c   Hekimgil, Mine ^c   Boyacioǧlu, Hayal ^c  

^a EGE UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes mellitus; Gingival crevicular fluid analysis; Growth factors, vascular endothelial; Periodontal diseases etiology

Indexed keywords

COLLAGEN; VASCULOTROPIN;

ADULT; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION; GINGIVA; GINGIVITIS; HUMAN; HUMAN TISSUE; MALE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PERIODONTAL DISEASE; PERIODONTITIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TISSUE DISTRIBUTION;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GINGIVA; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERIODONTITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542270755     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.1.91     Document Type: Article

References (56)

1. Cornelini R, Artese I, Rubini C, et al. Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral Maxillofac Implants 2001;16:389-393.
2. Gavin JB. Ultrastructural features of chronic marginal gingivitis. J Periodontal Res 1970;5:19-29.
3. Zoellner H, Chapple CC, Hunter N. Microvasculature in gingivitis and chronic periodontitis: Disruption of vascular networks with protracted inflammation. Microsc Res Tech 2002;56:15-31.
4. Mirgazizov MZ, Khamitova NKh, Mamaeva EV, Akhmetzianov AN. Possibilities of using laser doppler flowmetry in evaluation of periodontal tissue status. Stomatologiia (Mosk) 2001;80:66-70.
5. Bonakdar MP, Barber PM, Newman HN. The vasculature in chronic adult periodontitis: A qualitative and quantitative study. J Periodontol 1997;68:50-58.
6. Johnson RB, Serio FG, Dal X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
7. Chapple CC, Kumar RK, Hunter N. Vascular remodeling in chronic inflammatory periodontal disease. J Oral Pathol Med 2000;29:500-506.
8. Carlile J, Harada K, Baillie R, et al. Vascular endothelial growth factor (VEGF) expression in oral tissues. Possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med 2001;30:449-457.
9. Matsushita K, Motani R, Sauta T, et al. Lipopolysaccaride enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infect Immun 1999; 67:1633-1639.
10. Michi Y, Morita I, Amagasa T, Murota S. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol 2000;36:81-88.
11. Nissen N, Polverini PJ, Koch AE, Volin MV, Gamelli RL, diPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
12. Senger DR, Van De Water L, Brown L, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324.
13. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993;91:2235-2243.
14. Taichman NS, Cruchley AT, Fletcher LM, et al. Vascular endothelial growth factor in normal human salivary glands and saliva. A possible role in the maintenance of mucosal hemostasis. Lab Invest 1998;78:869-875.
15. Becit N, Ceviz M, Kocak H, et al. The effect of vascular endothelial growth factor on angiogenesis. An experimental study. Eur J Vasc Endovasc Surg 2001;22:310-316.
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995;146:1029-1039.
17. Ferrara N, Houck K, Jakeman L, Leung D. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
18. Lantieri LA, Martin-Garcia N, Wechsler J, Mitrofanoff M, Raulo Y, Baruch JP. Vascular endothelial growth factor expression in expanded tissue. A possible mechanism of angiogenesis in tissue expansion. Plast Reconstr Surg 1998;101:392-398.
19. Connolly DT. Vascular permeability factor. A unique regulator of blood vessel function. J Cell Biochem 1991;47: 219-223.
20. Hayashibara T, Yamata Y, Miyanishi T, et al. Vascular endothelial growth factor and cellular chemotaxis: A possible autocrine pathway in adult T-cell invasion. Clin Cancer Res 2001;7:2719-2726.
21. Mattioli M, Barboni B, Turriani M, et al. Follicle activation involves vascular endothelial growth factor production and increased blood vessel extension. Biol Reprod 2001;65:1014-1019.
22. Bernardini S, Fauconnet S, Chabannes E, Henry PC, Adessi G, Bittard H. Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. J Urol 2001;166:1275-1279.
23. Nakagawa K, Chen YX, Ishibashi H, et al. Angiogenesis and its regulation. Roles of vascular endothelial cell growth factor. Semin Thromb Hemost 2000;26:61-66.
24. Sakuta T, Matsushita K, Yamaguchi N, et al. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J Med Microbiol 2001; 50:233-237.
25. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 2000;77:113-119.
26. Endo M, Yanagisawa K, Tsuchida K, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res 2001;33:317-322.
27. Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. A case-control study. Diabetes Care 2001;24:516-521.
28. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res 1998;44:873-875.
29. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001;12:993-1000.
30. Pinter E, Haigh J, Naggy A, Madri JA. Hyperglycemia induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol 2001;158:1199-1206.
31. Santilli F, Spagnoli A, Mohn A, et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 2001;86(8):3871-3876.
32. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000;53:53-67.
33. Benjamin LE. Glucose, VEGF-A and diabetic complications. Am J Pathol 2001;158:1181-1184.
34. Beck EL, Mc Millen MA, Scott P, Angus LD, Shaftan GW. The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth factor mediated angiogenesis in rats. Clin Sci (Colch) 2002;48:424S-429S.
35. Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 1998;152:1453-1462.
36. Lu M, Adamis AP. Vascular endothelial growth factor gene regulation and activation in diabetic retinopathy. Ophthalmol Clin North Am 2002;15:69-79.
37. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab 1997;23:125-130.
38. Tolentino MJ, Mc Leod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA. Pathologic features of vascular endothelial growth factor induced retinopathy in the nonhuman primate. Am J Ophthalmol 2002;133:373-385.
39. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001;12: 1734-1741.
40. Lee HB, Chung SH, Chu WS, Kim JK, Ha H. Peritoneal dialysis in diabetic patients. Am J Kidney Dis 2001;38: S200-S203.
41. Oliver RC, Tervonen T. Diabetes-A risk factor for periodontitis in adults. J Periodontol 1994;65:530-538.
42. Murrah VA. Diabetes mellitus and oral manifestations. J Oral Pathol 1985;14:271-281.
43. Murakami S, Takayama S, Ikezawa K, et al. Regeneration of periodontal tissues by basic fibroblast growth factor. J Periodontal Res 1999;34:425-430.
44. Steinberg AD, Lipowski J, LeBreton G. In vitro platelet serotonin secretion and inhibition variously treated root surfaces. J Periodontol 1992;63:33-38.
45. Zoellner H, Hunter N. Perivascular hyaline deposits in inflamed gingival tissues. J Oral Pathol Med 1989;18: 333-338.
46. Pinchback JS, Gibbins JR, Hunter N. Vascular colocalisation of proteolytic enzymes and proteinase inhibitors in advanced periodontitis. J Pathol 1996;179:326-332.
47. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschacler E. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 1998;186:186-191.
48. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 1998;33:491-499.
49. Oyama T, Sakuta T, Matsushita K, Maruyama I, Nagaoka S, Torii M. Effects of roxitromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells. J Periodontol 2000;71:1546-1553.
50. Morozumi T, Kubota T, Sugita N, Ohsawa Y, Yamazaki K, Yoshie H. Elevated mRNA expression for supervillin and vascular endothelial growth factor in human neutrophils stimulated with lipopolysaccharide from porphyromonas gingivalis. J Periodontal Res 2001;36:160-168.
51. Kubota T, Morozumi T, Shimizu K, Sugita N, Kobayashi T, Yoshie H. Differential gene expression in neutrophils from patients with generalized aggressive periodontitis. J Periodontal Res 2001;36:390-397.
52. Ünlü F, Güneri P, Hekimgil M, Yeşilbek B, Boyacioǧlu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol 2003;74:181-187.
53. American Academy of Periodontology. Parameters of Care. Chicago: American Academy of Periodontology; 1996.
54. Silness J, Löe H. Periodontal disease in pregnancy. II. Prevalence and severity. Acta Odontol Scand 1963;21: 532-551.
55. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 2000;10:349-357.
56. Lennard CM, Patel A, Wilson J, et al. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 2001;129:552-558.